Skip to content

Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes

Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02477605
Enrollment
137
Registered
2015-06-23
Start date
2015-07-16
Completion date
2016-08-31
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreoretinal Disease

Brief summary

The purpose of this study is to compare the treatment day change between immediate postoperative and immediate preoperative intraocular pressure (IOP) between 27-gauge and 23-gauge vitrectomy instruments.

Detailed description

Required follow-up for this study is 3 months post treatment.

Interventions

DEVICECONSTELLATION® 27-gauge Combined Surgical Pak

Sterile single-use supplies necessary to perform 1 vitrectomy surgery: 1 ULTRAVIT® 27-gauge 7500 cuts per minute (cpm) vitrectomy probe and a 27-gauge EDGEPLUS® Valved Entry System comprised of 3 trocar/cannulas and related accessories.

DEVICECONSTELLATION® 23-gauge Combined Surgical Pak

Sterile single-use supplies necessary to perform 1 vitrectomy surgery: 1 ULTRAVIT® 23-gauge 7500 cuts per minute (cpm) vitrectomy probe and a 23-gauge EDGEPLUS® trocar/cannula set comprising of 3 trocars/cannulas and related accessories.

Microincisional pars plana vitrectomy (PPV) surgery for the treatment of various vitreoretinal diseases ranging from simple to advanced cases

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing and able to provide informed consent and attend all required study visits; * Requires vitrectomy in at least one eye; * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Previous vitrectomy or glaucoma surgery; * Planned treatment requires scleral buckling, combined procedures (eg, cataract surgery), silicone oil, and expansive gas other than sterile air; * Treated with topical IOP lowering medication(s) at any time from baseline assessment to time of surgery; * Pregnant or planning to become pregnant during the course of the trial; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Intraocular Pressure (IOP) on Operative DayDay 0 preoperative, Day 0 postoperativeIOP (fluid pressure inside the eye) was assessed using the study specified tono-pen and measured in millimeters of mercury (mmHg). Change was defined as the difference between immediate postoperative IOP and immediate preoperative IOP. A greater change in IOP may indicate a less stable posterior chamber and/or a more invasive surgery.

Secondary

MeasureTime frameDescription
Mean Conjunctival Edema Score at Week 1Week 1 post operativeConjunctival edema (swelling) was assessed during examination by the investigator and graded on a scale of 0-3, where 0=Absent and 3=Severe. Each sclerotomy wound was graded as infusion, vitrectomy probe, and illuminator and the average of the three was the overall Conjunctival Edema Score at the visit. Only one eye (study eye) contributed to the analysis.
Mean Post-operative Pain Rating at Day 1Day 1 post operativeThe subject was asked to rate post-operative pain in the study eye using a score of 0-10, where 0=no pain and 10=the worst pain imaginable.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from 6 study centers located in the US.

Pre-assignment details

Of the 137 enrolled, 1 subject was exited as a screen failure prior to randomization. This reporting group includes all randomized subjects (136).

Participants by arm

ArmCount
27-Gauge
CONSTELLATION® 27-gauge combined surgical pak used during vitrectomy surgery
68
23-Gauge
CONSTELLATION® 23-gauge combined surgical pak used during vitrectomy surgery
68
Total136

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdministered gas during surgery01
Overall StudyDiscontinued prior to treatment10
Overall StudyLost to Follow-up02
Overall StudyWithdrawal by Subject01

Baseline characteristics

Characteristic27-Gauge23-GaugeTotal
Age, Continuous65.8 years
STANDARD_DEVIATION 11.55
67.0 years
STANDARD_DEVIATION 11.65
66.4 years
STANDARD_DEVIATION 11.57
Sex: Female, Male
Female
43 Participants45 Participants88 Participants
Sex: Female, Male
Male
25 Participants23 Participants48 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
deaths
Total, all-cause mortality
0 / 660 / 660 / 660 / 690 / 690 / 69
other
Total, other adverse events
18 / 660 / 660 / 6614 / 690 / 690 / 69
serious
Total, serious adverse events
15 / 660 / 660 / 6616 / 690 / 691 / 69

Outcome results

Primary

Mean Change in Intraocular Pressure (IOP) on Operative Day

IOP (fluid pressure inside the eye) was assessed using the study specified tono-pen and measured in millimeters of mercury (mmHg). Change was defined as the difference between immediate postoperative IOP and immediate preoperative IOP. A greater change in IOP may indicate a less stable posterior chamber and/or a more invasive surgery.

Time frame: Day 0 preoperative, Day 0 postoperative

Population: Intent-to-Treat Analysis Set. Number Analyzed is the number of subjects with data.

ArmMeasureValue (MEAN)Dispersion
27-GaugeMean Change in Intraocular Pressure (IOP) on Operative Day-0.40 mmHGStandard Deviation 6.603
23-GaugeMean Change in Intraocular Pressure (IOP) on Operative Day-3.05 mmHGStandard Deviation 7.639
Secondary

Mean Conjunctival Edema Score at Week 1

Conjunctival edema (swelling) was assessed during examination by the investigator and graded on a scale of 0-3, where 0=Absent and 3=Severe. Each sclerotomy wound was graded as infusion, vitrectomy probe, and illuminator and the average of the three was the overall Conjunctival Edema Score at the visit. Only one eye (study eye) contributed to the analysis.

Time frame: Week 1 post operative

Population: Intent-to-Treat Set. Number Analyzed is the number of subjects with data.

ArmMeasureValue (MEAN)Dispersion
27-GaugeMean Conjunctival Edema Score at Week 10.02 units on a scaleStandard Deviation 0.124
23-GaugeMean Conjunctival Edema Score at Week 10.10 units on a scaleStandard Deviation 0.246
Secondary

Mean Post-operative Pain Rating at Day 1

The subject was asked to rate post-operative pain in the study eye using a score of 0-10, where 0=no pain and 10=the worst pain imaginable.

Time frame: Day 1 post operative

Population: Intent-to-Treat Analysis Set. Number Analyzed is the number of subjects with data.

ArmMeasureValue (MEAN)Dispersion
27-GaugeMean Post-operative Pain Rating at Day 10.9 units on a scaleStandard Deviation 1.75
23-GaugeMean Post-operative Pain Rating at Day 10.6 units on a scaleStandard Deviation 1.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026